EVEREST II high risk study based UK cost-effectiveness analysis of MitraClip® in patients with severe mitral regurgitation ineligible for conventional repair/replacement surgery

Author: Mealing Stuart   Feldman Ted   Eaton James   Singh Moushmi   Scott David A.  

Publisher: Informa Healthcare

ISSN: 1369-6998

Source: Journal of Medical Economics, Vol.16, Iss.11, 2013-11, pp. : 1317-1326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract